The role of the angiotensin II type I receptor blocker telmisartan in the treatment of non-alcoholic fatty liver disease: a brief review
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The role of the angiotensin II type I receptor blocker telmisartan in the treatment of non-alcoholic fatty liver disease: a brief review
Authors
Keywords
-
Journal
HYPERTENSION RESEARCH
Volume 41, Issue 6, Pages 394-405
Publisher
Springer Nature
Online
2018-04-13
DOI
10.1038/s41440-018-0040-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Angiotensin II type 1 receptor antagonists in animal models of vascular, cardiac, metabolic and renal disease
- (2016) Martin C. Michel et al. PHARMACOLOGY & THERAPEUTICS
- Effect of telmisartan on histological activity and fibrosis of non-alcoholic steatohepatitis: A 1-year randomized control trial
- (2016) Shahinul Alam et al. Saudi Journal of Gastroenterology
- NAFLD: A multisystem disease
- (2015) Christopher D. Byrne et al. JOURNAL OF HEPATOLOGY
- Current pharmacological therapies for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
- (2015) Yoshihisa Takahashi WORLD JOURNAL OF GASTROENTEROLOGY
- Treatment of Nonalcoholic Steatohepatitis in Adults: Present and Future
- (2015) S. Gitto et al. Gastroenterology Research and Practice
- Nonalcoholic steatohepatitis: emerging targeted therapies to optimize treatment options
- (2015) Sandra Milić et al. Drug Design Development and Therapy
- Alamandine
- (2014) Daniel C. Villela et al. CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION
- Interactions Between the Intestinal Microbiome and Liver Diseases
- (2014) Bernd Schnabl et al. GASTROENTEROLOGY
- Angiotensin 1–7: A peptide for preventing and treating metabolic syndrome
- (2014) Sérgio Henrique Sousa Santos et al. PEPTIDES
- The role of renin-angiotensin system modulation on treatment and prevention of liver diseases
- (2014) Simone Moreira de Macêdo et al. PEPTIDES
- Non-alcoholic fatty liver disease: What has changed in the treatment since the beginning?
- (2014) Bülent Baran WORLD JOURNAL OF GASTROENTEROLOGY
- Systematic review with meta-analysis: non-alcoholic steatohepatitis - a case for personalised treatment based on pathogenic targets
- (2013) Z. M. Younossi et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Mas receptor deficiency is associated with worsening of lipid profile and severe hepatic steatosis in ApoE-knockout mice
- (2013) Analina R. Silva et al. AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY
- Chronic blockade of angiotensin AT1receptors improves cardinal symptoms of metabolic syndrome in diet-induced obesity in rats
- (2013) Helge Müller-Fielitz et al. BRITISH JOURNAL OF PHARMACOLOGY
- Oral Formulation of Angiotensin-(1–7) Improves Lipid Metabolism and Prevents High-Fat Diet–Induced Hepatic Steatosis and Inflammation in Mice
- (2013) John David Feltenberger et al. HYPERTENSION
- Effect of Telmisartan or Losartan for Treatment of Nonalcoholic Fatty Liver Disease: Fatty Liver Protection Trial by Telmisartan or Losartan Study (FANTASY)
- (2013) Takumi Hirata et al. International Journal of Endocrinology
- Telmisartan attenuates hepatic fibrosis in bile duct-ligated rats
- (2012) En-tong Yi et al. ACTA PHARMACOLOGICA SINICA
- The renin-angiotensin system: a target of and contributor to dyslipidemias, altered glucose homeostasis, and hypertension of the metabolic syndrome
- (2012) Kelly Putnam et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
- (2012) Naga Chalasani et al. HEPATOLOGY
- Angiotensin-converting enzyme 2, angiotensin-(1–7) and Mas: new players of the renin–angiotensin system
- (2012) Robson A S Santos et al. JOURNAL OF ENDOCRINOLOGY
- Angiotensin II type 1 receptor antagonist prevents hepatic carcinoma in rats with nonalcoholic steatohepatitis
- (2012) Yosui Tamaki et al. JOURNAL OF GASTROENTEROLOGY
- Exercise induces renin–angiotensin system unbalance and high collagen expression in the heart of Mas-deficient mice
- (2012) Gislaine G. Guimarães et al. PEPTIDES
- Decreased hepatic gluconeogenesis in transgenic rats with increased circulating angiotensin-(1-7)
- (2012) Victor Bilman et al. PEPTIDES
- Increased circulating angiotensin-(1–7) protects white adipose tissue against development of a proinflammatory state stimulated by a high-fat diet
- (2012) Sérgio Henrique S. Santos et al. REGULATORY PEPTIDES
- Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults
- (2011) G. Vernon et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Double blockade of angiotensin II (AT1)-receptors and ACE does not improve weight gain and glucose homeostasis better than single-drug treatments in obese rats
- (2011) Anja Miesel et al. BRITISH JOURNAL OF PHARMACOLOGY
- Toll-like receptor signaling in liver regeneration, fibrosis and carcinogenesis
- (2011) Ekihiro Seki et al. HEPATOLOGY RESEARCH
- The renin-angiotensin system: a link between obesity, inflammation and insulin resistance
- (2011) N. S. Kalupahana et al. Obesity Reviews
- Angiotensin-(1–7) Mas-receptor deficiency decreases peroxisome proliferator-activated receptor gamma expression in adipocytes
- (2011) Érica Guilhen Mario et al. PEPTIDES
- Improved Lipid and Glucose Metabolism in Transgenic Rats With Increased Circulating Angiotensin-(1-7)
- (2010) Sérgio Henrique S. Santos et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Comparative effects of telmisartan, sitagliptin and metformin alone or in combination on obesity, insulin resistance, and liver and pancreas remodelling in C57BL/6 mice fed on a very high-fat diet
- (2010) Vanessa Souza-Mello et al. CLINICAL SCIENCE
- Nonalcoholic Fatty Liver Disease
- (2010) Kathryn Law et al. Clinics in Liver Disease
- Angiotensin II type 1 receptor-independent beneficial effects of telmisartan on dietary-induced obesity, insulin resistance and fatty liver in mice
- (2010) X. Rong et al. DIABETOLOGIA
- Prevalence of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis Among a Largely Middle-Aged Population Utilizing Ultrasound and Liver Biopsy: A Prospective Study
- (2010) Christopher D. Williams et al. GASTROENTEROLOGY
- Relationship between the pattern of hepatic iron deposition and histological severity in nonalcoholic fatty liver disease
- (2010) James E. Nelson et al. HEPATOLOGY
- Evolution of inflammation in nonalcoholic fatty liver disease: The multiple parallel hits hypothesis
- (2010) Herbert Tilg et al. HEPATOLOGY
- Meta-Analysis of Renin-Angiotensin-Aldosterone Blockade for Heart Failure in Presence of Preserved Left Ventricular Function
- (2010) Christophe Meune et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS
- Insulin Resistance in Obesity as the Underlying Cause for the Metabolic Syndrome
- (2010) Emily J. Gallagher et al. MOUNT SINAI JOURNAL OF MEDICINE
- Trilogy of ACE2: A peptidase in the renin–angiotensin system, a SARS receptor, and a partner for amino acid transporters
- (2010) Keiji Kuba et al. PHARMACOLOGY & THERAPEUTICS
- The renin angiotensin system and the metabolic syndrome
- (2010) Annette D. de Kloet et al. PHYSIOLOGY & BEHAVIOR
- Losartan reduces liver expression of plasminogen activator inhibitor-1 (PAI-1) in a high fat-induced rat nonalcoholic fatty liver disease model
- (2009) Maria Soledad Rosselli et al. ATHEROSCLEROSIS
- Does telmisartan prevent hepatic fibrosis in rats with alloxan-induced diabetes?
- (2009) Zekai Halici et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Devil and angel in the renin–angiotensin system: ACE–angiotensin II–AT1 receptor axis vs. ACE2–angiotensin-(1–7)–Mas receptor axis
- (2009) Masaru Iwai et al. HYPERTENSION RESEARCH
- Telmisartan attenuates progression of steatohepatitis in mice: role of hepatic macrophage infiltration and effects on adipose tissue
- (2009) Hiroshi Kudo et al. LIVER INTERNATIONAL
- Renin-angiotensin system in the pathogenesis of liver fibrosis
- (2009) Regina Maria Pereira et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Angiotensin-receptor blockers as therapy for mild-to-moderate hypertension-associated non-alcoholic steatohepatitis
- (2009) Eugen Florin Georgescu et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Local adipose tissue renin-angiotensin system
- (2008) Lisa A. Cassis et al. CURRENT HYPERTENSION REPORTS
- Liver-Specific Peroxisome Proliferator-Activated Receptor Target Gene Regulation by the Angiotensin Type 1 Receptor Blocker Telmisartan
- (2008) M. Clemenz et al. DIABETES
- Recent advances in the angiotensin-converting enzyme 2-angiotensin(1-7)-Mas axis
- (2008) Robson A. S. Santos et al. EXPERIMENTAL PHYSIOLOGY
- Angiotensin II-induced non-alcoholic fatty liver disease is mediated by oxidative stress in transgenic TG(mRen2)27(Ren2) rats
- (2008) Yongzhong Wei et al. JOURNAL OF HEPATOLOGY
- Renin-angiotensin system revisited
- (2008) F. Fyhrquist et al. JOURNAL OF INTERNAL MEDICINE
- Telmisartan, Ramipril, or Both in Patients at High Risk for Vascular Events
- (2008) NEW ENGLAND JOURNAL OF MEDICINE
- Angiotensin AT2 receptors: control of renal sodium excretion and blood pressure
- (2008) Robert M. Carey et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Anti-inflammatory and anti-oxidant properties of telmisartan in cultured human umbilical vein endothelial cells
- (2007) Silvana Cianchetti et al. ATHEROSCLEROSIS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now